Table 2.
The clinicopathological characteristics of 336 patients with gastric cancer.
| Variables | PLR < 133 (165 cases) | PLR ≥ 133 (171 cases) | X2 value | P value |
|---|---|---|---|---|
| Sex | 1.221 | 0.296 | ||
| Male | 121 | 116 | ||
| Female | 44 | 55 | ||
| Age (years) | 0.316 | 0.574 | ||
| <59 | 76 | 84 | ||
| ≥59 | 89 | 87 | ||
| mMGC/pMGC | 0.889 | 0.346 | ||
| mMGC | 116 | 112 | ||
| pMGC | 49 | 59 | ||
| Tumor size (cm) | 12.861 | <0.001∗ | ||
| <5.25 | 91 | 61 | ||
| ≥5.25 | 74 | 110 | ||
| Chemotherapy | 2.427 | 0.119 | ||
| Yes | 69 | 86 | ||
| No | 96 | 85 | ||
| R0/R1&2 resection | 2.594 | 0.107 | ||
| R0 | 143 | 137 | ||
| R1/R2 | 22 | 34 | ||
| pT | 15.887 | 0.001∗ | ||
| T1 | 15 | 3 | ||
| T2 | 25 | 12 | ||
| T3 | 19 | 24 | ||
| T4 | 106 | 132 | ||
| pN | 15.730 | 0.003∗ | ||
| N0 | 45 | 27 | ||
| N1 | 35 | 28 | ||
| N2 | 39 | 38 | ||
| N3a | 33 | 45 | ||
| N3b | 13 | 33 | ||
| pTNM | 12.523 | <0.001∗ | ||
| I+II | 65 | 37 | ||
| III | 100 | 134 | ||
| Tumor location | 12.906 | 0.024∗ | ||
| L | 109 | 86 | ||
| M | 16 | 31 | ||
| U | 18 | 17 | ||
| LM | 13 | 25 | ||
| MU | 6 | 5 | ||
| LMU | 3 | 7 | ||
| Leukocyte | 3.768 | 0.052 | ||
| <6.17 | 82 | 103 | ||
| ≥6.17 | 83 | 68 | ||
| Neutrophil | 2.609 | 0.106 | ||
| <3.31 | 83 | 71 | ||
| ≥3.31 | 82 | 100 | ||
| Hemoglobin | 35.619 | <0.001∗ | ||
| <125.1 | 46 | 103 | ||
| ≥125.1 | 119 | 68 | ||
| Fibrinogen | 10.791 | 0.001∗ | ||
| <3.31 | 100 | 73 | ||
| ≥3.31 | 65 | 98 | ||
| Albumin | 4.031 | 0.045∗ | ||
| <40.1 | 65 | 86 | ||
| ≥40.1 | 100 | 85 | ||
| Globulin | 2.121 | 0.145 | ||
| <29.2 | 119 | 135 | ||
| ≥29.2 | 46 | 36 | ||
| Platelet | 60.100 | <0.001∗ | ||
| <243 | 119 | 51 | ||
| ≥243 | 46 | 120 | ||
| Total gastrectomy | 10.402 | 0.001∗ | ||
| Yes | 32 | 60 | ||
| No | 133 | 111 | ||
| NLR | 56.385 | <0.001∗ | ||
| <1.6 | 88 | 25 | ||
| ≥1.6 | 77 | 146 |
∗ P < 0.05; L = lower; M = middle; U = upper; NLR = neutrophil-to-lymphocyte ratio; MGC = mucinous gastric carcinoma.